ING3’s diminished nuclear expression in breast cancer correlates with aggressive disease via p21 signaling, while ING4’s involvement in multiple regulatory pathways, including the NF-κB/miR-155 axis, mitigates tumor progression. The gene discussed is ING4; the disease is neoplasm.